☆ 4.7 Article

Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data

JOURNAL OF AUTOIMMUNITY (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

The SARS-CoV-2 as an instrumental trigger of autoimmunity

Arad Dotan et al.

Summary: This article emphasizes the association between COVID-19 and the development of multiple types of autoantibodies and autoimmune diseases in patients. It highlights the potential molecular resemblance between SARS-CoV-2 and host self-components, leading to hyper-stimulation of the immune system. Recognizing autoimmune manifestations of COVID-19 is crucial for managing the ongoing pandemic and its long-term consequences.

AUTOIMMUNITY REVIEWS (2021)

添加到收藏夹

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Hematology

Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2

Thomas Thiele et al.

Summary: After vaccination with different brands of COVID-19 vaccines, some healthy vaccinees tested positive for anti-PF4/polyanion antibodies, but most of these antibodies did not induce platelet activation. Pathogenic platelet-activating antibodies causing VITT were uncommon after vaccination.

BLOOD (2021)

添加到收藏夹

Article Hematology

An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination

Ingvild Hausberg Sorvoll et al.

Summary: This study investigated the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in a population recently vaccinated with AZD1222. The results showed a low prevalence of both conditions among Norwegian health care workers after vaccination with AZD1222, with the majority of participants having normal platelet counts and negative immunoassay results.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Medicine, General & Internal

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Andreas Greinacher et al.

Summary: After vaccination with ChAdOx1 nCov-19, rare immune thrombotic thrombocytopenia can occur due to platelet-activating antibodies against PF4, resulting in various thrombotic events. Most patients in this case series were women, with fatal outcomes such as cerebral venous thrombosis and intracranial hemorrhage. Additional studies are needed to further investigate and understand this phenomenon.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study

Anton Pottegard et al.

Summary: This study assessed rates of cardiovascular and haemostatic events in Denmark and Norway after vaccination with the Oxford-AstraZeneca vaccine ChAdOx1-S, finding increased rates of venous thromboembolic events among recipients. Despite slightly higher rates of thrombocytopenia/coagulation disorders and bleeding, the overall safety outcomes were largely reassuring.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Immunology

Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data

Luigi Cari et al.

Summary: The study compared the frequency of severe adverse events (SAEs) between ChAdOx1 nCoV-19 Covid-19 and BNT162b2 Covid-19 vaccines in Europe, showing that recipients of ChA vaccine have higher risks in bleeding, thrombocytopenia, and blood clots. Young people and women of reproductive age may be at higher risk following ChA vaccination.

JOURNAL OF AUTOIMMUNITY (2021)

添加到收藏夹

News Item Multidisciplinary Sciences

COVID VACCINES AND BLOOD CLOTS: WHAT RESEARCHERS KNOW SO FAR

Heidi Ledford

NATURE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

C. R. Simpson et al.

Summary: Analysis of data from the EAVE II cohort in Scotland has shown that a first dose of the ChAdOx1 nCoV-19 vaccine may be associated with increased risks of idiopathic thrombocytopenic purpura, arterial thromboembolic events, and hemorrhagic events. However, there were no positive associations found between the BNT162b2 vaccine and these adverse events.

NATURE MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Noam Barda et al.

Summary: The study found that after receiving the BNT162b2 vaccine, most adverse events were not associated with an increased risk, although there was a slight increase in the risk of myocarditis. On the other hand, infection with the Covid-19 virus significantly increased the risk of many serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Dead cell and debris clearance in the atherosclerotic plaque: Mechanisms and therapeutic opportunities to promote inflammation resolution

Umesh Kumar Dhawan et al.

Summary: Deficient clearance of dead cells and debris in atherosclerosis is linked to inflammation and thrombotic cardiovascular events. Novel therapeutic strategies to enhance dead cell and debris clearance are crucial for promoting inflammation resolution and plaque stabilization.

PHARMACOLOGICAL RESEARCH (2021)

添加到收藏夹

Article Immunology

Pathogenic Mechanisms of Vaccine-Induced Immune Thrombotic Thrombocytopenia in People Receiving Anti-COVID-19 Adenoviral-Based Vaccines: A Proposal

Bruno Azzarone et al.

Summary: VITT is a rare life-threatening syndrome characterized by thrombotic symptoms and thrombocytopenia, potentially associated with the administration of AVV anti-Covid19 vaccines.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Letter Immunology

Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?

Francesco Caso et al.

AUTOIMMUNITY REVIEWS (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19

Yaqing Zhou et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan et al.

NATURE (2020)

添加到收藏夹

Article Immunology

Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine

Darja Kanduc et al.

IMMUNOLOGIC RESEARCH (2020)

添加到收藏夹

Article Cell Biology

Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19

Yu Zuo et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

添加到收藏夹

Review Virology

Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms

Maria K. Smatti et al.

VIRUSES-BASEL (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Immunity and Inflammation in Atherosclerosis

Dennis Wolf et al.

CIRCULATION RESEARCH (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Frequency of Cardiac Rhythm Abnormalities in a Half Million Adults

Shaan Khurshid et al.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2018)

添加到收藏夹

Article Medicine, General & Internal

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Dan H. Barouch et al.

LANCET (2018)

添加到收藏夹

Review Virology

Simian adenoviruses as vaccine vectors

Susan J. Morris et al.

FUTURE VIROLOGY (2016)

添加到收藏夹

Review Immunology

Infection-immunity liaison: Pathogen-driven autoimmune-mimicry (PDAIM)

Yukihiko Saeki et al.

AUTOIMMUNITY REVIEWS (2014)

添加到收藏夹

Article Nursing

CAUSES FOR THE UNDERREPORTING OF ADVERSE DRUG EVENTS BY HEALTH PROFESSIONALS: A SYSTEMATIC REVIEW

Fabiana Rossi Varallo et al.

REVISTA DA ESCOLA DE ENFERMAGEM DA USP (2014)

添加到收藏夹

Article Multidisciplinary Sciences

A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity

Matthew D. J. Dicks et al.

PLOS ONE (2012)

添加到收藏夹

Article Hematology

Underreporting of Hemorrhagic and Thrombotic Complications of Pharmaceuticals to the US Food and Drug Administration: Empirical Findings for Warfarin, Clopidogrel, Ticlopidine, and Thalidomide from the Southern Network on Adverse Reactions (SONAR)

Thomas J. Moore et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2012)

添加到收藏夹

Article Immunology

International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations

Dan H. Barouch et al.

VACCINE (2011)

添加到收藏夹

Review Public, Environmental & Occupational Health

Under-reporting of adverse drug reactions - A systematic review

Lorna Hazell et al.

DRUG SAFETY (2006)

添加到收藏夹

Article Immunology

Infection, vaccines and other environmental triggers of autoimmunity

V Molina et al.

AUTOIMMUNITY (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.